Preferred Label : Antiangiogenic Drug Combination TL-118;
NCIt definition : A proprietary, oral suspension containing a combination of agents comprised of a nonsteroidal
anti-inflammatory agent, an alkylating agent, a histamine H2 antagonist and a sulfonamide
with potential anti-angiogenic and antineoplastic activities. Antiangiogenic drug
combination TL-118 is administrated as a specific dosing regimen and may result in
a synergistic effect and reduce angiogenesis and inhibit tumor cell proliferation.;
Drug name : Hamsa-1;
Molecule name : TL-118;
Origin ID : C99761;
UMLS CUI : C3274907;
Semantic type(s)
- UMLS correspondences (same concept)
- TL-118 [MeSH Supplementary Concept]
- concept_is_in_subset
